Paper Details

  1. Home
  2. Paper Details

Remyelination in humans due to a retinoid-X receptor agonist is age-dependent.

Author: BrownJ William L, ChardDeclan T, ColesAlasdair J, CunniffeNick G, FranklinRobin J M, McMurranChristopher E, MichellAndrew W, MukherjeeTrisha

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study investigates the age-dependent decline in remyelination efficiency in patients with multiple sclerosis. The researchers evaluated the effects of bexarotene, a retinoid-X receptor agonist, on visual evoked potential latency and magnetization transfer ratio in patients with chronic optic neuropathy. The findings suggest that bexarotene's remyelinating effects are more pronounced in younger patients, highlighting the need for age-specific remyelinating therapies.
Paper Details　
Original Abstract of the Article :
Remyelination efficiency declines with advancing age in animal models, but this has been harder to demonstrate in people with multiple sclerosis. We show that bexarotene, a putatively remyelinating retinoid-X receptor agonist, shortened the visual evoked potential latency in patients with chronic op...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268872/

データ提供：米国国立医学図書館（NLM）

Remyelination in Humans: An Age-Dependent Desert Oasis

The study explores the fascinating world of remyelination, the process of repairing damaged myelin sheaths, the protective covering around nerve fibers. This process is crucial for restoring neurological function in conditions like multiple sclerosis (MS). The researchers investigated the impact of bexarotene, a retinoid-X receptor agonist, on remyelination efficiency in patients with chronic optic neuropathy, focusing on the role of age in this process.

A Diminishing Oasis: Age's Impact on Remyelination

The study revealed that bexarotene's remyelinating effects were significantly age-dependent. Patients under 42 years old showed a positive response to bexarotene, with improved visual evoked potential latency, a measure of nerve signal transmission speed. However, this effect diminished with increasing age, indicating a decline in remyelination capacity as we age. Imagine a desert oasis gradually drying up over time; the study shows how remyelination potential may decline as we age.

Understanding Age's Role: A Crucial Step

This research highlights the importance of considering age when developing remyelination therapies for neurological disorders. Understanding the age-dependent decline in remyelination capacity is crucial for designing treatments that are effective across the lifespan. Just as a desert traveler adapts their strategies based on the changing landscape, researchers must adapt their approaches to remyelination therapies to account for age-related differences.

Dr. Camel's Conclusion

This study underscores the importance of addressing the age-dependent decline in remyelination capacity. By recognizing this crucial factor, researchers can develop remyelination therapies that are more effective and accessible to a wider range of patients. Just as a desert explorer adapts their strategies to navigate diverse landscapes, the field of remyelination research is embracing innovative approaches to address the challenges of age and restore neurological function.
Date :
  1. Date Completed 2022-07-12
  2. Date Revised 2022-07-21
Further Info :

Pubmed ID

35587315

DOI: Digital Object Identifier

PMC9268872

Related Literature

Article Analysis
・Effects of bexarotene
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.